These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1654007)

  • 1. [The immunogenicity of a cultured inactivated hepatitis A vaccine].
    Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV
    Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins].
    Poleshchuk VF; Balaian MS; Sobol' AV; Titova IP; Guliaeva TV; Dokin VP; Kusov IuIu
    Vopr Virusol; 1990; 35(4):296-9. PubMed ID: 2256314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The specific safety of a cultured inactivated vaccine against hepatitis A].
    Kusov IuIu; Orlova TM; Panina LI; Kazachkov IuA; Nel'ga IV; El'bert LB; Krutianskaia GL; Poleshchuk VF; Sobol' AV; Titova IP
    Vopr Virusol; 1991; 36(2):156-9. PubMed ID: 1652870
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules.
    Troisi CL; Hollinger FB; Krause DS; Pickering LK
    Vaccine; 1997 Oct; 15(15):1613-7. PubMed ID: 9364691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible approaches to develop vaccines against hepatitis A.
    D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.
    Flehmig B; Heinricy U; Pfisterer M
    Lancet; 1989 May; 1(8646):1039-41. PubMed ID: 2565998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of inactivated purified tissue culture vaccine against hepatitis A (HepAvac) assessed in laboratory rodents.
    Elbert LB; Lisitzina EA; Kusov YY; Balayan MS
    Vaccine; 1992; 10(12):828-32. PubMed ID: 1333687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine].
    Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J
    Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.